The federal government has had “more than adequate time to correct” its unlawful Medicare Part B payment cuts for hospitals’ 340B purchased drugs from 2018 through 2022 and should promptly reimburse the hospitals it harmed, the American Hospital Association said late Tuesday.
AHA was responding to the Center for Medicare and Medicaid Services’ (CMS) outpatient prospective payment system (OPPS) rule for calendar year 2023, published late Tuesday, that reinstates the Medicare payment rate to the historic formula of average sales price (ASP) plus 6% from ASP minus 22.5%. The nearly 30% lower pay rate was declared illegal by the U.S. Supreme Court in June.
The federal government has had “more than adequate time to correct” its unlawful Medicare Part B payment cuts for hospitals’ 340B purchased drugs from 2018 through 2022 and should promptly reimburse the hospitals it harmed, the American Hospital Association said late Tuesday.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
